WENSHENG WU: Open Payments
NPI 1144871344 · LIBERTYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 22 payments from 13 companies in 2025. Trend: 2023 $325 · 2024 $2,361 · 2025 $2,430
Food & beverage: $2,350Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $467 |
| Astellas Pharma US Inc | 3 | $389 |
| PFIZER INC. | 3 | $337 |
| Janssen Biotech, Inc. | 2 | $296 |
| E.R. Squibb & Sons, L.L.C. | 1 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $102 |
Products named: RYBREVANT, Xtandi, IBRANCE, BREYANZI, TALZENNA, Padcev, IMDELLTRA (AMG757), IMFINZI.
Industry payments across IL — which companies pay providers there.
